John P. Vasilakos

Comparison of human B cell activation by TLR7 and TLR9 agonists (2008)

Hanten, John A, Vasilakos, John P, Riter, Christie L, Neys, Lori, Lipson, Kenneth E, Alkan, Sefik S, ...

Abstract Background Human B cells and plasmacytoid dendritic cells (pDC) are the only cells known to express both TLR7 and TLR9. Plasmacytoid dendritic cells are the primary IFN-α producing cells in...

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists (2007)

Birmachu, Woubalem, Gleason, Raymond M, Bulbulian, Barbara J, Riter, Christie L, Vasilakos, John P, Lipson, Kenneth E, ...

Abstract Background Plasmacytoid Dendritic Cells (pDC) comprise approximately 0.2 to 0.8% of the blood mononuclear cells and are the primary type 1 interferon (IFN), producing cells, secreting high...

Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells (2007)

Ramakrishna, Venky, Vasilakos, John P, Tario, Joseph D, Berger, Marc A, Wallace, Paul K, Keler, Tibor

Abstract Previously, we have successfully targeted the mannose receptor (MR) expressed on monocyte-derived dendritic cells (DCs) using a fully human MR-specific antibody, B11, as a vehicle to deliver...

Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells

Ramakrishna, Venky, Vasilakos, John P, Tario, Joseph D, Berger, Marc A, Wallace, Paul K, Keler, Tibor

Previously, we have successfully targeted the mannose receptor (MR) expressed on monocyte-derived dendritic cells (DCs) using a fully human MR-specific antibody, B11, as a vehicle to deliver whole...

Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN

Ahonen, Cory L., Doxsee, Christie L., McGurran, Sean M., Riter, Tony R., Wade, William F., Barth, Richard J., ...

Toll-like receptors are important in the activation of innate immunity, and CD40 is a molecule critical for many T and B cell responses. Whereas agonists for either pathway have been used as vaccine...